ESCI期刊Clinical Pharmacology-Advances and Applications 2024/2025影响因子:3.192 (CLIN PHARMACOL-ADV A) (1179-1438). (PHARMACO

显示全部楼层 · 发表于 2025-3-27 05:10:52

Submitted on: 29 October 2006. Revised on: 19 December 2006. Accepted on: 11 February 2007. ___________________Clinical Pharmacology-Advances and Applications

显示全部楼层 · 发表于 2025-3-27 09:09:31

显示全部楼层 · 发表于 2025-3-27 10:49:42

显示全部楼层 · 发表于 2025-3-27 17:17:23

Submitted on: 13 September 2000. Revised on: 09 January 2001. Accepted on: 24 February 2001. ___________________Clinical Pharmacology-Advances and Applications

显示全部楼层 · 发表于 2025-3-27 19:57:59

Submitted on: 20 March 2024. Revised on: 07 July 2024. Accepted on: 04 September 2024. ___________________Clinical Pharmacology-Advances and Applications

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-8 03:51
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved

ESCI期刊Clinical Pharmacology-Advances and Applications 2024/2025影响因子:3.192 (CLIN PHARMACOL-ADV A) (1179-1438). (PHARMACO

浏览过的版块